A Clinical Study of TQB3824 in Subjects With Advanced Cancer

Summary

TQB3824 blocks function of a specific protein called Cell Division Cycle 7 (CDC7) kinase in the human body, which plays important roles in the maintenance of DNA replication forks and DNA damage response pathways. This study will evaluate the safety, tolerability and pharmacokinetics of TQB3824.

Timeline

Start

2021-08-31

Primary completion

2024-08

Completion

2024-12

Drugs

Indications